Yüklüyor......
Checkpoint molecule PD-1-assisted CD8(+) T lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
PURPOSE: The aim of this study was to determine whether CD8(+) T lymphocyte and its checkpoint-associated module programmed cell death protein 1 (PD-1)/main ligand of PD-1 (PD-L1) pathway impact overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC) treated with tyrosine kinas...
Kaydedildi:
| Yayımlandı: | Cancer Manag Res |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6138960/ https://ncbi.nlm.nih.gov/pubmed/30237743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S172039 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|